510(k) Report

510(k) · Cleared

Cleared

Biogennix RPC

K093342510(k) TraditionalCleared Jul 29, 2010276-day reviewClass II21 CFR 888.3045

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Biogennix, LLC · MQV Filler, Bone Void, Calcium Compound

Cleared on Jul 29, 2010 as substantially equivalent to K990131 (Interpore Cross Intl., 1999) after a 276-day review. Its family tree reaches back 1 generation to 1999. 5 later devices descend from it.

Decided
Jul 29, 2010
Review
276 days
Class
Class II
Product code
MQV
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K990131 (1999). 5 later devices descend from it, 2 citing it directly.

Descendants, by year cleared 2015: 1 descendant cleared2014: 1 descendant cleared2019: 1 descendant cleared2020: 2 descendants clearedK990131 · Pro Osteon Implant 500R Resorbable Bone Graft Substitute · Interpore Cross Intl. · 19991995200020052010201520202025
Descendants, by generation 1 generation forward: 2 descendants2 generations forward: 3 descendants K990131 · Pro Osteon Implant 500R Resorbable Bone Graft Substitute · Interpore Cross Intl. · 19990
  1. Root · 1 generation backK990131 Pro Osteon Implant 500R Resorbable Bone Graft SubstituteInterpore Cross Intl. · 1999
  2. This deviceK093342 Biogennix RPCBiogennix, LLC · 2010
  3. Descendant · cites it directly · 4 of its ownK132377 Osteospan MorpheusBiogennix, LLC · 2014
  4. Descendant · cites it directly · 2 of its ownK142828 osteoSPAN MorpheusBiogennix · 2015
  5. Descendant · 2 generations on · 0 of its ownK193487 Agilon StripBiogennix, LLC · 2020
  6. Descendant · 2 generations on · 0 of its ownK193168 Agilon MoldableBiogennix, LLC · 2020
  7. Descendant · 2 generations on · 0 of its ownK190371 Morpheus-CBiogennix, LLC · 2019

Most influential descendants

Showing 5 of 5 · See all
  • K132377Osteospan MorpheusBiogennix, LLC · 2014 · cites it directly4descendants
  • K142828osteoSPAN MorpheusBiogennix · 2015 · cites it directly2descendants
  • K193487Agilon StripBiogennix, LLC · 2020 · 2 generations on0descendants
  • K193168Agilon MoldableBiogennix, LLC · 2020 · 2 generations on0descendants
  • K190371Morpheus-CBiogennix, LLC · 2019 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K990131Pro Osteon Implant 500R Resorbable Bone Graft SubstituteInterpore Cross Intl.1999—
0 (this device)K093342Biogennix RPCBiogennix, LLC2010—
+1K132377Osteospan MorpheusBiogennix, LLC2014—
+1K142828osteoSPAN MorpheusBiogennix2015—
+2K193487Agilon StripBiogennix, LLC2020—
+2K193168Agilon MoldableBiogennix, LLC2020—
+2K190371Morpheus-CBiogennix, LLC2019—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201410
201510
201910
202020
FIG. 1 — Lineage of K093342, 1999–2020Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MQV? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new MQV device

  1. #1 K232315 Catalyst Bone Void Fillerscore 25.2 · 25 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K990131Pro Osteon Implant 500R Resorbable Bone Graft Substitute
Summary page 1
…MQV Panel Orthopedic Regulation Number: 21 CFR 888.3045 4. Predicate Pro Osteon 5OOR (K990131), marketed by Interpore Cross Device 5. Device Biogennix RPC is an osteoconductive, open cell, resorbable ceramic. The…
Interpore Cross Intl.1999—

Also cleared against K990131: 17 other devices →

What descends from it? (5)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K132377Osteospan MorpheusBiogennix, LLC20144
K142828osteoSPAN MorpheusBiogennix20152

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • Of its descendants, K132377 (Biogennix, LLC, 2014) has gone furthest, with 4 descendants of its own.
  • 17 other devices also cite its predicate K990131.

How does its category compare?

All MQV devices

MQV Filler, Bone Void, Calcium Compound: FDA decisions, review times, recalls and adverse event reports over 20 years. 2010, this device’s year, is highlighted.

FDA decisions per year · MQV

14in 2025

2007: 352008: 322009: 232010: 172011: 162012: 92013: 122014: 202015: 182016: 82017: 172018: 232019: 132020: 152021: 82022: 92023: 212024: 282025: 142026 (partial year): 5
2007high 35 (2007) · low 8 (2016)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MQV

57in 2025

2007: 144 days median2008: 102 days median2009: 180 days median2010: 147 days median2011: 92 days median2012: 107 days median2013: 197 days median2014: 153 days median2015: 184 days median2016: 214 days median2017: 124 days median2018: 124 days median2019: 90 days median2020: 132 days median2021: 88 days median2022: 118 days median2023: 74 days median2024: 55 days median2025: 57 days median2026 (partial year): 96 days median
2007high 214 (2016) · low 55 (2024)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · MQV

1in 2025

2007: 52008: 32009: 12011: 62012: 32013: 22016: 12017: 12018: 22020: 12023: 32024: 22025: 12026 (partial year): 4
2007high 6 (2011) · low 0 (2010)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · MQV

57in 2025

2007: 672008: 712009: 812010: 682011: 1142012: 1492013: 2232014: 1112015: 1252016: 1062017: 1072018: 862019: 652020: 1262021: 1012022: 472023: 1202024: 682025: 57
2007high 223 (2013) · low 47 (2022)2025

MAUDE reports naming product code MQV, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200735144567
200832102371
200923180181
201017147068
201116926114
201291073149
2013121972223
2014201530111
2015181840125
201682141106
2017171241107
201823124286
20191390065
2020151321126
20218880101
20229118047
202321743120
20242855268
20251457157
20265964—

What is it indicated for?

Biogennix RPC is indicated only for bony voids or gaps that are not intrinsic to the stability of the bony structure. Biogennix RPC is indicated to be gently packed into bony voids or gaps of the skeletal system (i.e., the extremities, spine and pelvis). These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the home. Biogennix PRC may be used as a bone graft extender in posterolateral spine fusion when mixed in a one to one ratio with autogenous bone graft. The product provides bone void filler that resorbs and is replaced with bone during the healing process.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K093342: Biogennix RPC.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K093342

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026